Chimeric (5) as is found in influenza virus-infected cells (2). To elucidate further some of the structural features involved in biogenesis, transport, and sorting of influenza HA, we have constructed and expressed chimeric cDNA clones in which the DNA encoding either the NH2 terminus or the COOH terminus of HA has been replaced with that of VSV G. In this report, we describe the properties of these chimeric proteins that have been expressed in CV1 cells and discuss the implication of these observations for translocation, sorting, and transport of the HA glycoprotein.
MATERIALS AND METHODSVirus Strains, Cells, and Plasmid Vectors. CV1P and CV1 cells were grown in Dulbecco's modified Eagle's medium (DME medium) supplemented with 10% fetal bovine serum. Virus stocks of A/WSN/33 (HlN1) strain of influenza virus were prepared in Madin-Darby bovine kidney (MDBK) cells as described (6). SVHA2 [simian virus 40 (SV40) late-replacement vector expressing WSN HA] and SVSal-32 (SV40 defective in T-antigen expression) were grown in CV1 cells (7). pG1 and pGR125 containing VSV G cDNA were obtained from John K. Rose (8, 9).We expressed the chimeric HAG and GHA cDNA employing the late SV40 promoter as described for HA (10). To produce a lytic infection, SVSal32, which provides late gene function, was used as a helper and virus stock was prepared as described (7).Antibodies and Immunofluorescent Staining. Anti-HA monoclonal antibody (H15A13-18) against PR8 virus was obtained from W. Gerhard. Anti-WSN antibody was prepared from rabbits. Procedures for intracellular and surface staining using indirect immunofluorescence have been described (7).Radiolabeling of Infected Cells and Analysis of Polypeptides. At 40-48 hr after infection, cells were labeled for 5-6 hr by using 3 ml of methionine-free DME medium supplemented with 2% dialyzed fetal bovine serum and 50 ,Ci of L-[35S]methionine per ml (1 Ci = 37 gBq). For tunicamycin treatment, cells were first pretreated for 1 hr at 37°C with tunicamycin (2 ,ug/ml) in DME medium containing 2% fetal bovine serum and then labeled with L-[35S]methionine (50 ,Ci/ml) in DME medium containing tunicamycin (2 ,ug/ml).Subsequently, cells were washed twice with cold Tris (25 mM)-buffered saline, scraped, pelleted, and lysed in RIPA buffer (0.05 M Tris, pH 7.4/0.15 M NaCl/1% Triton X-100/1% sodium deoxycholate/0.1% NaDodSO4) (11, 12) for 10 min at 0°C. Nuclei were removed by centrifuging 15 min in an Eppendorf centrifuge and the supernatant was incubated for 1 hr at 4°C with 2 ,l of anti-WSN antibody. The antigen-antibody complexes were isolated by using protein ASepharose, washed four times, and analyzed on a 10% NaDodSO4/polyacrylamide gel (12-14).Endoglycosidase H (endo H) Treatment. At 40-48 hr after infection, cells were labeled for 2 hr with L-[35S]methionine as described above. The cells were then washed with methionine-free DME medium and incubated further in DME medium containing 2% fetal bovine serum for 3 hr. Cells were subsequently lysed and immunoprecipitated as described abo...